Paper41245563
Dual-Functional Amine-Modified Aluminum-Doped MCM-41 Nanoparticles for Concurrent Zoledronic Acid Adsorption and Geranylgeraniol Delivery for Prevention of Medication-Related Osteonecrosis of the Jaw.
Pichaipanich P and 6 others. ACS Mater Au, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Dual-Functional Amine-Modified Aluminum-Doped MCM-41 Nanoparticles for Concurrent Zoledronic Acid Adsorption and Geranylgeraniol Delivery for Prevention of Medication-Related Osteonecrosis of the Jaw. Papers, record 41245563. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41245563
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dual-Functional Amine-Modified Aluminum-Doped MCM-41 Nanoparticles for Concurrent Zoledronic Acid Adsorption and Geranylgeraniol Delivery for Prevention of Medication-Related Osteonecrosis of the Jaw.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35496416 | Comparison of drug release behavior of bacterial cellulose loaded with ibuprofen and propranolol hydrochloride. | RSC Adv | 2021 | https://conductscience.org/library/papers/35496416 | PubMed |
| 2 | 24496019 | Surface characteristics determining the cell compatibility of ionically cross-linked alginate gels. | Biomed Mater | 2014 | https://conductscience.org/library/papers/24496019 | PubMed |
| 3 | 16787058 | Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. | J Am Chem Soc | 2006 | https://conductscience.org/library/papers/16787058 | PubMed |
| 4 | 21630682 | Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. | ACS Nano | 2011 | https://conductscience.org/library/papers/21630682 | PubMed |
| 5 | 21294526 | Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. | ACS Nano | 2011 | https://conductscience.org/library/papers/21294526 | PubMed |
| 6 | 20664588 | Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma. | Br J Cancer | 2010 | https://conductscience.org/library/papers/20664588 | PubMed |
| 7 | 34540258 | Antibacterial and osteogenic activities of clindamycin-releasing mesoporous silica/carboxymethyl chitosan composite hydrogels. | R Soc Open Sci | 2021 | https://conductscience.org/library/papers/34540258 | PubMed |
| 8 | 34113452 | Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation. | R Soc Open Sci | 2021 | https://conductscience.org/library/papers/34113452 | PubMed |
| 9 | 38327595 | Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw. | J Oral Biol Craniofac Res | 2024 | https://conductscience.org/library/papers/38327595 | PubMed |
| 10 | 31174333 | Synthetic Calcium Phosphate Ceramics as a Potential Treatment for Bisphosphonate-Related Osteonecrosis of the Jaw. | Materials (Basel) | 2019 | https://conductscience.org/library/papers/31174333 | PubMed |
| 11 | 29461260 | Hemolysis and immune regulation. | Curr Opin Hematol | 2018 | https://conductscience.org/library/papers/29461260 | PubMed |
| 12 | 33654732 | Evaluating Whole Blood Clotting in vitro on Biomaterial Surfaces. | Bio Protoc | 2020 | https://conductscience.org/library/papers/33654732 | PubMed |
| 13 | 34805177 | Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34805177 | PubMed |
| 14 | 38144102 | Insights on the Synthesis of Al-MCM-41 with Optimized Si/Al Ratio for High-Performance Antibiotic Adsorption. | ACS Omega | 2023 | https://conductscience.org/library/papers/38144102 | PubMed |
| 15 | 19538981 | Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. | Toxicol Appl Pharmacol | 2009 | https://conductscience.org/library/papers/19538981 | PubMed |
| 16 | 23419136 | Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of the jaw. | Oral Dis | 2014 | https://conductscience.org/library/papers/23419136 | PubMed |
| 17 | 38248578 | Biomimetic Collagen Membranes as Drug Carriers of Geranylgeraniol to Counteract the Effect of Zoledronate. | Biomimetics (Basel) | 2023 | https://conductscience.org/library/papers/38248578 | PubMed |
| 18 | 28902456 | Safety and efficacy of hydroxyapatite scaffold in the prevention of jaw osteonecrosis in vivo. | J Biomed Mater Res B Appl Biomater | 2018 | https://conductscience.org/library/papers/28902456 | PubMed |
| 19 | 28820251 | Aluminum Doped MCM-41 Nanoparticles as Platforms for the Dual Encapsulation of a CO-Releasing Molecule and Cisplatin. | Inorg Chem | 2017 | https://conductscience.org/library/papers/28820251 | PubMed |
| 20 | 11931958 | Bisphosphonate chelating agents. Coordination ability of 1-phenyl-1-hydroxymethylene bisphosphonate towards Cu(2+) ions. | J Inorg Biochem | 2002 | https://conductscience.org/library/papers/11931958 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41245563
GET https://conductscience.org/api/papers/v1/41245563/references?page=2